Related content

A New Highly Specific Method for Predicting the Carcinogenic Potential of Pharmaceuticals in Rodents Using Enhanced MCASE QSAR-ES Software

By Matthews E.J.   Contrera J.F.  

Regulatory Toxicology and Pharmacology, Vol. 28, Iss. 3, 1998-12 ,pp. : 242-264

Academic Press

Access to resources Recommend Favorite

Evaluation of the Carcinogenic Potential of Pharmaceuticals: Opportunities Arising from the International Conference on Harmonisation

By Monro A.M.  

Drug Safety, Vol. 18, Iss. 5, 1998-05 ,pp. : 309-319

Adis International

Access to resources Recommend Favorite

The use of molecular similarity indices in the determination of a bioactive conformation

By Castro A.   Richards W.G.  

European Journal of Medicinal Chemistry, Vol. 33, Iss. 7, 1998-07 ,pp. : 617-623

Elsevier

Access to resources Recommend Favorite

QSAR Modeling of Carcinogenic Risk Using Discriminant Analysis and Topological Molecular Descriptors

By  

Current Drug Discovery Technologies, Vol. 2, Iss. 2, 2005-06 ,pp. : 55-67

Bentham Science Publishers

Access to resources Recommend Favorite

In vivo murine hepatic microRNA and mRNA expression signatures predicting the (non-)genotoxic carcinogenic potential of chemicals

By Melis Joost   Derks Kasper   Pronk Tessa   Wackers Paul   Schaap Mirjam   Zwart Edwin   IJcken Wilfred   Jonker Martijs   Breit Timo   Pothof Joris   Steeg Harry   Luijten Mirjam  

Archives of Toxicology, Vol. 88, Iss. 4, 2014-04 ,pp. : 1023-1034

Springer Publishing Company

Access to resources Recommend Favorite